Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder.

  • Authors : Yoon G; Department of Psychiatry, VA Connecticut Healthcare System, Yale University School of Medicine, New Haven, Connecticut.; Petrakis IL

Subjects: Alcoholism/Alcoholism/Alcoholism/*drug therapy ; Depressive Disorder, Major/Depressive Disorder, Major/Depressive Disorder, Major/*drug therapy ; Ketamine/Ketamine/Ketamine/*therapeutic use

  • Source: JAMA psychiatry [JAMA Psychiatry] 2019 Mar 01; Vol. 76 (3), pp. 337-338.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Academic Journal

Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study.

  • Authors : Latif ZE; Department of Research and Development in Mental Health, Akershus University Hospital, Lørenskog, Norway.; Norwegian Center for Addiction Research, University of Oslo, Oslo, Norway.

Subjects: Anxiety/Anxiety/Anxiety/*drug therapy ; Buprenorphine, Naloxone Drug Combination/Buprenorphine, Naloxone Drug Combination/Buprenorphine, Naloxone Drug Combination/*therapeutic use ; Depression/Depression/Depression/*drug therapy

  • Source: JAMA psychiatry [JAMA Psychiatry] 2019 Feb 01; Vol. 76 (2), pp. 127-134.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Academic Journal

Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.

  • Authors : Green TC; Department of Emergency Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island.

Subjects: Health Plan Implementation*; Buprenorphine/Buprenorphine/Buprenorphine/*therapeutic use ; Drug Overdose/Drug Overdose/Drug Overdose/*mortality

  • Source: JAMA psychiatry [JAMA Psychiatry] 2018 Apr 01; Vol. 75 (4), pp. 405-407.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Academic Journal

Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease).

  • Authors : Ibrahim O; Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio.; Hogan SR

Subjects: Quality of Life*; Naltrexone/Naltrexone/Naltrexone/*therapeutic use ; Narcotic Antagonists/Narcotic Antagonists/Narcotic Antagonists/*therapeutic use

  • Source: JAMA dermatology [JAMA Dermatol] 2017 Oct 01; Vol. 153 (10), pp. 1015-1017.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print

Record details

×
Academic Journal

Treatment of Hailey-Hailey Disease With Low-Dose Naltrexone.

  • Authors : Albers LN; Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.; Arbiser JL

Subjects: Quality of Life*; Naltrexone/Naltrexone/Naltrexone/*therapeutic use ; Narcotic Antagonists/Narcotic Antagonists/Narcotic Antagonists/*therapeutic use

  • Source: JAMA dermatology [JAMA Dermatol] 2017 Oct 01; Vol. 153 (10), pp. 1018-1020.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print

Record details

×
Academic Journal

Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder.

  • Authors : Saloner B; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.

Subjects: Buprenorphine* ; Naltrexone*; Adolescent

  • Source: JAMA pediatrics [JAMA Pediatr] 2017 Aug 01; Vol. 171 (8), pp. 729-731.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589544 Publication Model: Print

Record details

×
Academic Journal

Medication-Based Treatment to Address Opioid Use Disorder.

  • Authors : Leshner AI; American Association for the Advancement of Science, Potomac, Maryland.; Dzau VJ

Subjects: Opiate Substitution Treatment*; Narcotic Antagonists/Narcotic Antagonists/Narcotic Antagonists/*therapeutic use ; Opioid-Related Disorders/Opioid-Related Disorders/Opioid-Related Disorders/*drug therapy

  • Source: JAMA [JAMA] 2019 Jun 04; Vol. 321 (21), pp. 2071-2072.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Editorial & Opinion

Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect.

  • Authors : Heifets BD; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California.; Williams NR

Subjects: Alcoholism* ; Ketamine*; Antidepressive Agents

  • Source: JAMA psychiatry [JAMA Psychiatry] 2019 Jun 01; Vol. 76 (6), pp. 657-658.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Editorial & Opinion

Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect-Reply.

  • Authors : Krystal JH; Department of Psychiatry, Veterans Affairs Connecticut Healthcare System, Yale University School of Medicine, New Haven, Connecticut.; Yoon G

Subjects: Alcoholism* ; Ketamine*; Antidepressive Agents

  • Source: JAMA psychiatry [JAMA Psychiatry] 2019 Jun 01; Vol. 76 (6), pp. 658-659.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Academic Journal

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.

Subjects: Alcohol Deterrents/Alcohol Deterrents/Alcohol Deterrents/*therapeutic use ; Alcoholism/Alcoholism/Alcoholism/*drug therapy ; Naltrexone/Naltrexone/Naltrexone/*therapeutic use

  • Source: JAMA psychiatry [JAMA Psychiatry] 2019 Apr 01; Vol. 76 (4), pp. 374-381.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
  • 1-10 of  392 results for ""NALTREXONE""